Evidence map›Paper›PMID 25070369›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2014

LKB1 and AMPK differentially regulate pancreatic β-cell identity.

Marina Kone, Timothy J Pullen, Gao Sun, Mark Ibberson, Aida Martinez-Sanchez, Sophie Sayers, Marie-Sophie Nguyen-Tu, Chase Kantor, Avital Swisa, Yuval Dor and 12 more

Open access · hybridAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 82 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Liver kinase B1 (LKB1) regulates the epigenetic landscape of mouse pancreatic beta cells.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2024
    Article
  7. Article
  8. Article
  9. DNA Methylation NearPediatric diabetes · 2023
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. The Role of Oxidative Stress in Pancreatic β Cell Dysfunction in Diabetes.International journal of molecular sciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 9 institutions in 5 countries.

Marina KoneSection of Cell Biology and.
Timothy J PullenSection of Cell Biology and.
Gao SunSection of Cell Biology and.
Mark IbbersonSwiss Institute of Bioinformatics and.
Aida Martinez-SanchezSection of Cell Biology and.
Sophie SayersSection of Cell Biology and.
Marie-Sophie Nguyen-TuSection of Cell Biology and.
Chase KantorSection of Cell Biology and.
Avital SwisaDepartment of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel;
Yuval DorDepartment of Developmental Biology and Cancer Research, Institute for Medical Research Israel-Canada, Hebrew University-Hadassah Medical School, Jerusalem, Israel;
Tracy GormanAstraZeneca Diabetes and Obesity Drug Discovery, Alderley Edge, UK;
Jorge FerrerSection of β-Cell Development, Division of Diabetes, Endocrinology, and Metabolism, Department of Medicine, and.
Bernard ThorensCenter for Integrative Genomics, University of Lausanne, Lausanne, Switzerland;
Frank ReimannMetabolic Research Laboratories, University of Cambridge, Cambridge, UK and.
Fiona GribbleMetabolic Research Laboratories, University of Cambridge, Cambridge, UK and.
James A McGintyPhotonics Group, Department of Physics, Imperial College London, London, UK;
Lingling ChenPhotonics Group, Department of Physics, Imperial College London, London, UK;
Paul M FrenchPhotonics Group, Department of Physics, Imperial College London, London, UK;
Fabian BirzeleBoehringer Ingelheim Pharma, Ingelheim, Germany.
Tobias HildebrandtBoehringer Ingelheim Pharma, Ingelheim, Germany.
Ingo UphuesBoehringer Ingelheim Pharma, Ingelheim, Germany.
Guy A RutterSection of Cell Biology and g.rutter@imperial.ac.uk.
The London College · GBImperial College London · GBBoehringer Ingelheim (Germany) · DEUniversity of Lausanne · CHWellcome/MRC Institute of Metabolic Science · GBApplied Photonics (United Kingdom) · GBAstraZeneca (United Kingdom) · GBConcern Foundation · USHadassah Medical Center · IL

Funding

Biotechnology and Biological Sciences Research Council BB/J015873/1Medical Research Council MC_UU_12012/3Medical Research Council MR/J0003042/1Medical Research Council MR/K001981/1Medical Research Council MR/L02036X/1Wellcome Trust 088357Wellcome Trust 098424Wellcome Trust 101033Wellcome Trust WT098424AIA
6 · The paper itself

Abstract

Fully differentiated pancreatic β cells are essential for normal glucose homeostasis in mammals. Dedifferentiation of these cells has been suggested to occur in type 2 diabetes, impairing insulin production. Since chronic fuel excess ("glucotoxicity") is implicated in this process, we sought here to identify the potential roles in β-cell identity of the tumor suppressor liver kinase B1 (LKB1/STK11) and the downstream fuel-sensitive kinase, AMP-activated protein kinase (AMPK). Highly β-cell-restricted deletion of each kinase in mice, using an Ins1-controlled Cre, was therefore followed by physiological, morphometric, and massive parallel sequencing analysis. Loss of LKB1 strikingly (2.0-12-fold, E<0.01) increased the expression of subsets of hepatic (Alb, Iyd, Elovl2) and neuronal (Nptx2, Dlgap2, Cartpt, Pdyn) genes, enhancing glutamate signaling. These changes were partially recapitulated by the loss of AMPK, which also up-regulated β-cell "disallowed" genes (Slc16a1, Ldha, Mgst1, Pdgfra) 1.8- to 3.4-fold (E < 0.01). Correspondingly, targeted promoters were enriched for neuronal (Zfp206; P = 1.3 × 10(-33)) and hypoxia-regulated (HIF1; P = 2.5 × 10(-16)) transcription factors. In summary, LKB1 and AMPK, through only partly overlapping mechanisms, maintain β-cell identity by suppressing alternate pathways leading to neuronal, hepatic, and other characteristics. Selective targeting of these enzymes may provide a new approach to maintaining β-cell function in some forms of diabetes.

Indexed as

AMP-Activated Protein KinasesAnimalsDiabetes Mellitus, Type 2InsulinInsulin-Secreting CellsMice, Inbred C57BLProtein Serine-Threonine KinasesSignal TransductionAMP-Activated Protein KinasesInsulinProtein Serine-Threonine KinasesStk11 protein, mousediabetesinsulin secretionisletRNASeq

Identifiers

PMID25070369
PMCPMC4377859
OpenAlexW2136938986

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.